Cargando…

A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures

PURPOSE OF REVIEW: Sedation for pain medicine procedures provides a unique challenge for proceduralists. Many patients dealing with pain are on chronic opioids and require higher doses of sedation for adequate procedural comfort. Chronic pain patients have various comorbidities including depression,...

Descripción completa

Detalles Bibliográficos
Autores principales: Koushik, Sarang S., Schwartz, Ruben H., Cherkalin, Denis, Sankar, Vignesh, Shaparin, Naum, Viswanath, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787743/
https://www.ncbi.nlm.nih.gov/pubmed/35076875
http://dx.doi.org/10.1007/s11916-022-01014-0
_version_ 1784639421286449152
author Koushik, Sarang S.
Schwartz, Ruben H.
Cherkalin, Denis
Sankar, Vignesh
Shaparin, Naum
Viswanath, Omar
author_facet Koushik, Sarang S.
Schwartz, Ruben H.
Cherkalin, Denis
Sankar, Vignesh
Shaparin, Naum
Viswanath, Omar
author_sort Koushik, Sarang S.
collection PubMed
description PURPOSE OF REVIEW: Sedation for pain medicine procedures provides a unique challenge for proceduralists. Many patients dealing with pain are on chronic opioids and require higher doses of sedation for adequate procedural comfort. Chronic pain patients have various comorbidities including depression, neuropsychiatric disorders, peripheral vascular disease, and renal impairment, among others [1]. These confounding variables make the overall treatment of their pain condition much more challenging. RECENT FINDINGS: For patients requiring intravenous (IV) sedation for their pain procedures, the constant need for access may render them a “difficult stick” over time. Another factor to consider is the increasing requirements by the hospital system needing IV sedatives and analgesics in the intensive care unit and operating rooms during the coronavirus (COVID-19) pandemic. SUMMARY: Sublingual sufentanil (SST) provides an excellent analgesic option for patients undergoing interventional pain procedures. The use of SST allows hospitals to preserve IV agents for more critical areas and mitigates the difficulty of obtaining IV access in patients.
format Online
Article
Text
id pubmed-8787743
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-87877432022-01-25 A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures Koushik, Sarang S. Schwartz, Ruben H. Cherkalin, Denis Sankar, Vignesh Shaparin, Naum Viswanath, Omar Curr Pain Headache Rep Chronic Pain Medicine (O Viswanath, Section Editor) PURPOSE OF REVIEW: Sedation for pain medicine procedures provides a unique challenge for proceduralists. Many patients dealing with pain are on chronic opioids and require higher doses of sedation for adequate procedural comfort. Chronic pain patients have various comorbidities including depression, neuropsychiatric disorders, peripheral vascular disease, and renal impairment, among others [1]. These confounding variables make the overall treatment of their pain condition much more challenging. RECENT FINDINGS: For patients requiring intravenous (IV) sedation for their pain procedures, the constant need for access may render them a “difficult stick” over time. Another factor to consider is the increasing requirements by the hospital system needing IV sedatives and analgesics in the intensive care unit and operating rooms during the coronavirus (COVID-19) pandemic. SUMMARY: Sublingual sufentanil (SST) provides an excellent analgesic option for patients undergoing interventional pain procedures. The use of SST allows hospitals to preserve IV agents for more critical areas and mitigates the difficulty of obtaining IV access in patients. Springer US 2022-01-25 2022 /pmc/articles/PMC8787743/ /pubmed/35076875 http://dx.doi.org/10.1007/s11916-022-01014-0 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Chronic Pain Medicine (O Viswanath, Section Editor)
Koushik, Sarang S.
Schwartz, Ruben H.
Cherkalin, Denis
Sankar, Vignesh
Shaparin, Naum
Viswanath, Omar
A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures
title A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures
title_full A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures
title_fullStr A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures
title_full_unstemmed A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures
title_short A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures
title_sort review of sublingual sufentanil tablet (sst) and its utility as an analgesic agent for pain procedures
topic Chronic Pain Medicine (O Viswanath, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787743/
https://www.ncbi.nlm.nih.gov/pubmed/35076875
http://dx.doi.org/10.1007/s11916-022-01014-0
work_keys_str_mv AT koushiksarangs areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT schwartzrubenh areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT cherkalindenis areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT sankarvignesh areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT shaparinnaum areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT viswanathomar areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT koushiksarangs reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT schwartzrubenh reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT cherkalindenis reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT sankarvignesh reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT shaparinnaum reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures
AT viswanathomar reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures